Phibro Animal Health | PAHC - Gross Profit On Sales


Phibro Animal Health reported $133.5M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Align Technology USD 757.43M 20.84M Jun/2026
ANI Pharmaceuticals USD 143.88M 19.7M Mar/2026
Aurora Cannabis CAD 29.79M 16.83M Mar/2026
Bristol-Myers Squibb USD 9.26B 1.19B Jun/2026
Canopy Growth CAD 8.26M 13.2M Mar/2026
Corcept Therapeutics USD 252.09M 90.07M Jun/2026
Eli Lilly USD 16.22B 301.7M Mar/2026
Henry Schein USD 1.03B 39M Jun/2026
Idexx Laboratories USD 779.09M 56.35M Jun/2026
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Merck USD 12.09B 1.24B Mar/2026
Nektar Therapeutics USD 10.86M 10.95M Mar/2026
Pacira USD 133.91M 7.27M Jun/2026
Phibro Animal Health USD 133.5M 12.6M Dec/2025
Prestige Brands USD 136.19M 10.11M Jun/2026
Supernus Pharmaceuticals USD 160.06M 30.7M Jun/2026
Zoetis USD 1.76B 140M Jun/2026